Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ACIP
Pharma
CDC backs Pfizer's maternal Abrysvo to protect infants from RSV
A CDC panel voted 11-1 in favor of recommending Pfizer's RSV vaccine Abrysvo for people who are between 32 weeks and 36 weeks pregnant.
Fraiser Kansteiner
Sep 25, 2023 11:08am
Endemic COVID vax market will take years to develop: Moderna CEO
Sep 13, 2023 2:11pm
RSV shots from Pfizer, GSK recommended for people 60 and older
Jun 22, 2023 8:40am
GSK and Pfizer RSV shots under CDC scrutiny, vote set for today
Jun 21, 2023 11:15am
Merck's Prevnar rival snags key pediatric nod
Jun 22, 2022 6:45am
Analysts expect an autumn rebound after COVID vax sales slump
Apr 21, 2022 4:03pm